###### Significance of this study

What is already known about this subject?
=========================================

-   Free fatty acids (FFAs) and their metabolites are important mediators of lipotoxicity, leading to the progression of non-alcoholic fatty liver disease (NAFLD).

-   The liver is an important organ in the regulation of hydrogen sulfide (H~2~S) metabolism, and H~2~S homeostasis plays an important role in hepatic lipotoxicity.

-   Reported evidence suggests that the cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE) system, which contributes to endogenous H~2~S biosynthesis, may be regulated by fatty acids. The role of the CBS/CSE system in the pathogenesis of NAFLD has been actively investigated, and the system is proposed to serve as a potential therapeutic target for NAFLD.

-   3-Mercaptopyruvate sulfurtransferase (MPST) is also an important enzyme that contributes to the generation of H~2~S by using 3-mercaptopyruvate as substrate in a pyridoxal-5′-phosphate (PLP)-independent way, which is different from the CBS/CSE system by way of using cysteine as substrate that is dependent on PLP.

What are the new findings?
==========================

-   FFAs induced upregulation of hepatic MPST protein expression in high-fat diet (HFD)-fed mice and patients with NAFLD.

-   Hepatic H~2~S synthesis is impaired in NAFLD models in vivo and in vitro. Partial knockdown of MPST significantly elevated H~2~S levels by directly interacting with and negatively regulating CSE.

-   Partial knockdown of MPST via adenovirus delivery of MPST short hairpin RNA or heterozygous deletion of the *Mpst* gene significantly ameliorated hepatic steatosis in HFD-fed mice. Small interfering RNA-mediated partial knockdown of MPST reduced fat accumulation, while MPST overexpression exacerbated lipid accumulation in FFA-treated L02 cells.

-   MPST upregulates the sterol regulatory element-binding protein 1c pathway, C-Jun N-terminal kinase phosphorylation and hepatic oxidative stress, which is mediated by inhibition of CSE/H~2~S.

How might it impact on clinical practice in the foreseeable future?
===================================================================

-   MPST may be a potential therapeutic target for NAFLD.

-   Inhibition of MPST may be a novel therapeutic strategy for the treatment of NAFLD.

Introduction {#s1}
============

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in Western countries, with a prevalence of 20%--30% in the general population.[@R1] The disease encompasses a broad spectrum of clinicopathology, ranging from simple steatosis to non-alcoholic steatohepatitis (NASH); the latter may further progress to liver cirrhosis and hepatocellular carcinoma.[@R3] The number of patients with NAFLD is growing at alarming rates worldwide. However, its pathogenesis remains poorly understood but is of great interest, since current therapeutic options are limited.

Emerging data indicate that the flux of fatty acids through the liver is increased in patients with NASH.[@R5] Free fatty acids (FFAs) and their metabolites are important mediators of lipotoxicity via the induction of lipid overaccumulation, which causes lipotoxic hepatocellular injury and the progression of NAFLD.[@R6] However, the exact mechanisms by which FFAs cause lipotoxicity remain unclear.

Hydrogen sulfide (H~2~S), which has been known for centuries as a toxic gas with the smell of rotten eggs,[@R7] has been established as the third gaseous signalling molecule following nitric oxide and carbon monoxide, participating in a wide range of physiological processes, including inflammation, apoptosis, vasorelaxation and neuromodulation.[@R8] The role of H~2~S in NAFLD has been received great attention over the last two decades. The liver is an important organ in the regulation of H~2~S metabolism.[@R11] Conversely, H~2~S plays critical roles in pathophysiology of liver diseases.[@R12] H~2~S protected against liver injury induced by ischemia reperfusion and carbon tetrachloride in rodents.[@R13] Recent studies revealed that the endogenous formation of H~2~S was impaired in high fat diet (HFD)-fed mice and rats with NASH.[@R16] Treatment with sodium hydrosulfide (NaHS), a H~2~S donor, prevented NASH in rodents by abating oxidative stress and suppressing inflammation.[@R17] These findings suggest that H~2~S homeostasis plays an important role in hepatic lipotoxicity. However, how H~2~S biosynthesis is regulated in NAFLD remains unclear.

In mammalian tissues, H~2~S can be produced from cysteine by pyridoxal-5′-phosphate (PLP)-dependent enzymes including cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE); the former is mainly expressed in the brain and the latter is expressed in the vasculature and liver.[@R20] 3-Mercaptopyruvate sulfurtransferase (MPST) is another enzyme PLP independently that uses 3-mercaptopyruvate as substrate to generate H~2~S.[@R21] The CBS/CSE system, which may be regulated by several fatty acids, has been actively investigated in the pathogenesis of NAFLD and proposed to serve as a potential therapeutic target for NAFLD.[@R22] However, the role of MPST in NAFLD has not been investigated. To date, whether MPST is involved in the regulation of hepatic lipid metabolism and in the pathogenesis of NAFLD remains unknown.

In this study, we investigated the underlying mechanisms by which fatty acids contribute to the pathogenesis of NAFLD, involving the role of MPST in the development of NAFLD. Our results provided novel evidence that FFAs stimulate the expression of hepatic MPST in NAFLD, and this upregulated MPST promotes NAFLD via inhibition of the CSE/H~2~S pathway.

Materials and methods {#s2}
=====================

Human samples {#s2a}
-------------

Liver biopsies from liver transplant donors who were healthy adults (n=19) and from patients with NAFLD (n=37) who underwent liver biopsies for suspected NAFLD or NASH or during liver surgeries were randomly selected from the liver biopsy samples recruited at the First Affiliated Hospital, College of Medicine, Zhejiang University; The Affiliated Hospital of Hangzhou Normal University; Renji Hospital, School of Medicine, Shanghai Jiao Tong University; Hangzhou Sixth People's Hospital; and Ningbo Medical Treatment Center Lihuili Hospital. The inclusion criteria and clinical characteristics of patients were provided in the online [supplementary data](#SP1){ref-type="supplementary-material"}. All liver tissue samples from patients used in this study were approved by the Ethics Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University, and all patients provided their written informed consent.
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Animal experiments {#s2b}
------------------

An intravenous hydrodynamic injection of adenovirus plasmids that contained green fluorescent protein (AD-GFP) coding sequence and MPST short hairpin RNA (AD-shMPST) was administered to male C57BL/6 mice to inhibit hepatic MPST expression. Heterozygous MPST-deficient (MPST^+/-^) mice on a C57BL/6 background were generated through frameshift mutation by TAL-effector nuclease system by Beijing ViewSolid Biotechnology (Beijing, China). Detailed explanations of generation strategy and all animal treatments are provided in the online supplementary data and online [supplementary figure 1](#SP1){ref-type="supplementary-material"}. All of the animal experiments were performed according to the guidelines approved by the Animal Care and Use Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University.

Other materials and methods are described in details in the online supplementary data.

Results {#s3}
=======

FFAs upregulate hepatic MPST expression in HFD-fed mice and in patients with NAFLD {#s3a}
----------------------------------------------------------------------------------

A previous study suggests that the CBS/CSE system may be regulated by FFAs.[@R22] Here we determined whether FFAs also regulate MPST. To test this hypothesis, we stimulated human hepatocyte cell lines with FFAs to establish in vitro models of hepatocyte steatosis (online [supplementary figure 2A, B](#SP1){ref-type="supplementary-material"}) and measured MPST expression. As illustrated in [figure 1A](#F1){ref-type="fig"} and online [supplementary figure 2C](#SP1){ref-type="supplementary-material"}, FFA treatment markedly upregulated MPST protein expression in FFA-stimulated L02 cells and 7701 cells. The blockade of NF-κB, an important downstream signal of FFAs,[@R23] reduced MPST expression ([figure 1B](#F1){ref-type="fig"}), while the overexpression of NF-κB/p65 enhanced MPST expression in FFA-stimulated L02 cells ([figure 1C](#F1){ref-type="fig"}). Next we examined whether FFAs also upregulate hepatic expression of MPST in vivo in HFD-fed mice, in which hepatic FFA levels were significantly elevated compared with controls ([figure 1D](#F1){ref-type="fig"}). As illustrated in [figure 1E](#F1){ref-type="fig"}, hepatic MPST protein expression was upregulated by approximately 1.5-fold in HFD-fed mice compared with control-diet-fed mice. Finally, we measured the levels of MPST protein in liver biopsies from patients with NAFLD, who exhibit increased FFA flux through the liver and elevated FFA concentrations in circulation (online [supplementary table 1](#SP1){ref-type="supplementary-material"}).[@R5] As shown in [figure 1F](#F1){ref-type="fig"}, immunohistochemistry experiments revealed markedly higher MPST protein expression within the cytoplasm of steatotic hepatocytes from patients with NAFLD compared with those from healthy controls, which was further confirmed by semiquantitative analysis of integral optical density of MPST positive areas. In addition, there was a positive correlation between the area of steatosis and MPST expression in the livers of patients with NAFLD ([figure 1G](#F1){ref-type="fig"}). Collectively, these data suggest that hepatic steatosis is associated with the FFA-induced upregulation of MPST in NAFLD.

![Upregulation of hepatic MPST expression in HFD-fed mice and patients with NAFLD: a role of FFAs.(A) L02 cells were treated with FFAs (1 mM) for 24 hours and then subjected to western blot analysis. (B) L02 cells were pretreated with pyrrolidine dithiocarbamate (NF-κB-specific inhibitor) (100 µM) for 1 hour and then treated with FFAs (1 mM) for 24 hours. Western blot analyses were performed. (C) pENTER-NF-κB/p65 plasmid or empty vector was transfected into L02 cells for 24 hours, followed by FFA treatment for 24 hours. Western blot analyses were performed. Liver tissues from 8-week HFD-fed and SCD-fed mice were obtained and subjected to intrahepatic FFA measurement (D) or western blot analysis (E). The bar graph indicates relative MPST abundance as quantified by densitometry from the immunoblots after normalisation to tubulin. (F) Representative images of immunohistochemistry staining of liver sections from controls (n=19) and patients with NAFLD (n=37). Original magnification, upper panel, ×200; lower panel, ×400. Semiquantitative analysis for the IOD of MPST positive areas is shown on the right of the images. (G) The area of steatosis positively correlated with MPST expression in the livers of patients with NAFLD. The results are expressed as the mean±SD of five mice per group or three independent experiments in A--E. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001. FFA, free fatty acid; HFD, high fat diet; IOD, integral optical density; MPST, 3-mercaptopyruvate sulfurtransferase; NAFLD, non-alcoholic fatty liver disease; SCD, standard chow diet.](gutjnl-2017-313778f01){#F1}

Partial knockdown of MPST markedly ameliorates hepatic steatosis in vivo {#s3b}
------------------------------------------------------------------------

To investigate the role of MPST in NAFLD, we first applied a recombinant adenovirus-mediated RNA interference approach to inhibit hepatic MPST expression in HFD-fed mice. As illustrated in [figure 2A](#F2){ref-type="fig"}, hepatic MPST expression was inhibited by approximately 40% at the messenger RNA (mRNA) level and 60% at the protein levels after the injection of the adenovirus. Notably, hepatic steatosis was improved after partial knockdown of hepatic MPST expression, as demonstrated by H&E and Oil Red O staining ([figure 2B](#F2){ref-type="fig"}) and the measurement of triglyceride (TG) and total cholesterol (TC) levels ([figure 2C](#F2){ref-type="fig"}). In addition, hepatic FFA levels and plasma TC levels were also decreased after MPST knockdown ([figure 2C](#F2){ref-type="fig"}, online [supplementary table 2](#SP1){ref-type="supplementary-material"}). There was also a trend toward reduction of plasma transaminase levels after MPST knockdown, but the difference did not reach statistical significance (online [supplementary table 2](#SP1){ref-type="supplementary-material"}).

![Partial knockdown of MPST markedly ameliorates hepatic steatosis in vivo. (A--C) HFD-fed C57/BL6 mice were given 1×10^9^ plaque-forming units of AD-GFP or adenovirus-mediated knockdown of MPST (AD-shMPST) via the tail vein every 2 weeks from the beginning of the experiment and were sacrificed after 8 weeks of HFD feeding. (A) Liver tissues were subjected to western blot analyses of MPST protein level (upper panel) or real-time qPCR for MPST mRNA level determination (lower panel). (B) Representative images of H&E and Oil Red O staining of livers infected with AD-GFP and AD-shMPST in HFD-fed mice. Original magnification ×400. (C) Liver tissues were subjected to intrahepatic FFA measurement (left panel), intrahepatic TG measurement (middle panel) or intrahepatic TC measurement (right panel). (D--F) MPST^+/+^ and MPST^+/-^ mice were fed an HFD for 8 weeks. (D) Liver tissues were subjected to western blot analyses of MPST protein level (upper panel) or real-time qPCR for MPST mRNA level determination (lower panel). (E) Representative images of H&E and Oil Red O staining of liver sections in HFD-fed MPST^+/+^ and MPST^+/-^ mice. Original magnification ×400. (F) Liver tissues were subjected to intrahepatic FFA measurement (left panel), intrahepatic TG measurement (middle panel) or intrahepatic TC measurement (right panel). The results are expressed as the mean ±SD of 3--5 mice per group from two independent experiments. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001. FFA, free fatty acid; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HFD, high fat diet; MPST, 3-mercaptopyruvate sulfurtransferase; qPCR, quantitative PCR; TC, total cholesterol; TG, triglyceride.](gutjnl-2017-313778f02){#F2}

To further investigate the effect of partial MPST deficiency in NAFLD, heterozygous MPST^+/--^ mice and their wild-type (WT) controls (MPST^+/+^) were placed on an HFD for 8 weeks. As illustrated in [figure 2D](#F2){ref-type="fig"}, hepatic MPST expression was decreased both at the protein and mRNA level in HFD-fed MPST^+/-^ mice compared with WT controls. In accordance with the effect of adenovirus-mediated MPST partial knockdown in HFD-fed mice, the partial deletion of MPST in MPST^+/-^ mice markedly ameliorated the fatty liver phenotype ([figure 2E](#F2){ref-type="fig"}); reduced hepatic FFAs and TG and TC contents ([figure 2F](#F2){ref-type="fig"}); and downregulated the plasma level of TC, particularly very-low-density lipoprotein cholesterol (online [supplementary table 3](#SP1){ref-type="supplementary-material"}). Plasma alanine transaminase and aspartate transaminase levels also showed a decreased tendency in HFD-fed MPST^+/-^ mice compared with WT controls (online [supplementary table 3](#SP1){ref-type="supplementary-material"}). Taken together, these results indicate that MPST is an important factor that facilitates the development of NAFLD.

Partial knockdown of MPST markedly attenuates while the overexpression of MPST exacerbates FFA-induced fat accumulation in hepatocytes in vitro {#s3c}
-----------------------------------------------------------------------------------------------------------------------------------------------

To investigate the effect of MPST on FFA-induced fat accumulation in hepatocytes in vitro, MPST expression was knocked down by MPST small interfering RNA (siRNA) in cultured hepatocytes ([figure 3A](#F3){ref-type="fig"}), and the knockdown significantly ameliorated fat accumulation (Oil Red O staining in [figure 3B](#F3){ref-type="fig"}) and intracellular TG and TC contents in the FFA-stimulated L02 cells ([figure 3C](#F3){ref-type="fig"}). In contrast, the overexpression of MPST via the transfection of the pIRES2-GFP-MPST plasmid ([figure 3D](#F3){ref-type="fig"}) markedly increased lipid accumulation ([figure 3E](#F3){ref-type="fig"}) and elevated TG and TC levels in the FFA-stimulated L02 cells ([figure 3F](#F3){ref-type="fig"}).

![Partial knockdown of MPST markedly attenuates while overexpression of MPST exacerbates FFA-induced fat accumulation in hepatocyte in vitro. (A--C) After transfection with scrambled siRNA (negative control) and MPST siRNA for 24 hours, L02 cells were treated with FFAs for 24 hours. (A) Western blot and qPCR analyses were performed to determine MPST expression. (B) Representative images of Oil Red O staining of L02 cells is shown. Original magnification ×400. (C) Intracellular TG and TC contents were determined. (D--F) After transfecting with plasmid containing GFP with or without full-length MPST DNA for 24 hours, L02 cells were treated with FFAs for 24 hours. (D) Western blot and qPCR analyses were performed to determine MPST expression. (E) Representative images of Oil Red O staining of L02 cells is shown. Original magnification ×400. (F) The intracellular TG and TC contents were determined. The results are expressed as the mean±SD of three independent experiments. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001. FFA, free fatty acid; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GFP, green fluorescent protein; MPST, 3-mercaptopyruvate sulfurtransferase; mRNA, messenger RNA; qPCR, quantitative PCR; siRNA, small interfering RNA; TC, total cholesterol; TG, triglyceride.](gutjnl-2017-313778f03){#F3}

Partial knockdown of hepatic MPST significantly increases H~2~S production {#s3d}
--------------------------------------------------------------------------

MPST is an important generator of H~2~S, which plays a critical role in the preservation of normal lipid metabolism under physiological or pathophysiological conditions.[@R12] Therefore, we hypothesized that MPST regulated hepatic steatosis via the regulation of H~2~S production. First, we measured H~2~S levels in HFD-fed mice and FFA-treated L02 cells. As illustrated in [figure 4](#F4){ref-type="fig"}, HFD feeding markedly downregulated hepatic H~2~S levels ([figure 4A](#F4){ref-type="fig"}), and FFA treatment reduced supernatant H~2~S levels of L02 cells ([figure 4B](#F4){ref-type="fig"}). Second, we examined the effects of partial knockdown of hepatic MPST on hepatic H~2~S levels in HFD-fed mice and in FFA-treated L02 cells. Unexpectedly, partial knockdown of MPST via adenovirus-mediated short hairpin RNA (shRNA) delivery or heterozygous deletion markedly upregulated hepatic H~2~S levels in HFD-fed mice ([figure 4C, D](#F4){ref-type="fig"}). Similar to the in vivo results, siRNA-mediated partial knockdown of MPST significantly elevated H~2~S levels in the supernatants of FFA-treated L02 cells ([figure 4E](#F4){ref-type="fig"}), whereas the overexpression of MPST reduced H~2~S levels in the supernatants of FFA-treated L02 cells ([figure 4F](#F4){ref-type="fig"}).

![Partial knockdown of MPST significantly increases H~2~S levels. (A) Liver tissues from 8-week HFD-fed and SCD-fed mice were subjected to intrahepatic H~2~S measurements. (B) L02 cells were treated with FFAs (1 mM) for 24 hours, and the fresh supernatants were collected to measure H~2~S levels. (C) HFD-fed C57/BL6 mice were given 1×10^9^ plaque-forming units of AD-GFP or adenovirus shMPST (AD-shMPST) via the tail vein every 2 weeks from the beginning of experiment and were sacrificed after 8 weeks of HFD feeding. Liver tissues were subjected to intrahepatic H~2~S measurement. (D) Quantification of intrahepatic H~2~S levels in HFD-fed MPST^+/+^ and MPST^+/-^ mice. (E) After transfection with scrambled siRNA (negative control) and MPST siRNA for 24 hours, L02 cells were treated with FFAs (1 mM) for 24 hours. The fresh supernatants were collected to measure H~2~S levels. (F) After transfection with plasmid containing GFP with or without full-length MPST DNA for 24 hours, L02 cells were treated with FFAs for 24 hours. The fresh supernatants were collected to measure H~2~S levels. The results are expressed as the mean±SD of 3--5 mice per group from two independent experiments or three independent experiments. \*p\<0.05, \*\*p\<0.01. FFA, free fatty acid; GFP, green fluorescent protein; H~2~S, hydrogen sulfide; HFD, high fat diet; MPST, 3-mercaptopyruvate sulfurtransferase; siRNA, small interfering RNA.](gutjnl-2017-313778f04){#F4}

Partial knockdown of hepatic MPST upregulates CSE through a direct MPST--CSE interaction {#s3e}
----------------------------------------------------------------------------------------

MPST is a generator of H~2~S in the liver, but unexpectedly, our above data revealed that partial knockdown of MPST elevated hepatic H~2~S levels in vivo and in vitro. To elucidate the molecular mechanisms of MPST on H~2~S metabolism in NAFLD, we searched potential MPST-interacting proteins in the STRING database[@R27] (online [supplementary figure 3A](#SP1){ref-type="supplementary-material"}) and found that MPST has a potential functional connection with CSE (also known as CTH), a main H~2~S-generating enzyme that is predominantly expressed in the vasculature and liver (online [supplementary figure 3B](#SP1){ref-type="supplementary-material"}). The score of prediction for the MPST--CSE interaction is 0.977, ranking the first place among the top 10 functional MPST-centric protein-interaction networks (online [supplementary figure 3C](#SP1){ref-type="supplementary-material"}). Interestingly, partial knockdown of MPST via either adenovirus-mediated shRNA delivery or heterozygous deletion significantly upregulated hepatic CSE expression in the HFD-fed mice ([figure 5A, B](#F5){ref-type="fig"}). The in vitro results also showed that partial knockdown of MPST significantly enhanced CSE expression ([figure 5C](#F5){ref-type="fig"}), while the overexpression of MPST decreased CSE expression in FFA-treated L02 cells ([figure 5D](#F5){ref-type="fig"}).

![Partial knockdown of MPST upregulates CSE by interacting with CSE. (A) HFD-fed C57/BL6 mice were given 1×10^9^ plaque-forming units of AD-GFP or AD-shMPST via the tail vein every 2 weeks from the beginning of experiment and were sacrificed after 8 weeks of HFD feeding. Liver tissues were subjected to western blot analyses of hepatic CSE protein expression. (B) Western blot analyses of hepatic CSE expression in HFD-fed MPST^+/+^ and MPST^+/-^ mice. (C) After transfection with scrambled siRNA (negative control) and MPST siRNA for 24 hours, L02 cells were treated with FFAs (1 mM) for 24 hours. Western blot analyses were performed to determine CSE protein expression. (D) After transfection with plasmid containing GFP with or without full-length MPST DNA for 24 hours, L02 cells were treated with FFAs (1 mM) for 24 hours. Western blot analyses were performed to determine CSE protein expression. (E) Immunoblot analysis of the interaction between MPST and CSE by co-immunoprecipitation. FFA-treated L02 cells were transfected with Flag-MPST and subjected to immunoprecipitation with an anti-Flag monoclonal antibody. Co-immunoprecipitated CSE was detected with an anti-CSE antibody. The results are expressed as the mean±SD of 3--5 mice per group from two independent experiments or three independent experiments. \*p\<0.05, \*\*p\<0.01. CSE, cystathionine γ-lyase; FFA, free fatty acid; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GFP, green fluorescent protein; HFD, high fat diet; IB, immunoblot; IP, immunoprecipitation; MPST, 3-mercaptopyruvate sulfurtransferase; siRNA, small interfering RNA.](gutjnl-2017-313778f05){#F5}

To verify the protein--protein interaction prediction, we prepared stably expressing Flag-MPST L02 cells and performed co-immunoprecipitation (co-IP) assays (online [supplementary figure 3D](#SP1){ref-type="supplementary-material"}). Our results revealed a marked interaction between MPST and CSE after FFA treatment ([figure 5E](#F5){ref-type="fig"}).

MPST attenuates H~2~S production and subsequently promotes fat accumulation in hepatocytes through a CSE-dependent mechanism {#s3f}
----------------------------------------------------------------------------------------------------------------------------

The above data suggest that MPST downregulates hepatic expression of CSE. Recent reports have identified a role of CSE/H~2~S in promoting fatty liver development.[@R25] Thus we hypothesized that the MPST-induced inhibition of H~2~S production is facilitated via the compensatory inhibition of CSE. To test this hypothesis, we first measured hepatic CSE levels. In contrast to the upregulation of MPST in HFD-fed mice and FFA-treated L02 cells as described above, hepatic expression of CSE was downregulated under these conditions (online [supplementary figure 4A, B](#SP1){ref-type="supplementary-material"}). Second, we used siRNA to knockdown CSE expression (online [supplementary figure 4C, D](#SP1){ref-type="supplementary-material"}) to define the role of CSE in the MPST-mediated regulation of H~2~S. As illustrated in [figure 6A](#F6){ref-type="fig"}, inhibition of MPST upregulated hepatic expression of CSE protein, while inhibition of CSE increased hepatic expression of MPST. [Figure 6B, C](#F6){ref-type="fig"} show that inhibition of MPST elevated supernatant H~2~S levels but decreased intracellular TG levels; both of these effects were reversed by CSE siRNA. Interestingly, a negative correlation between H~2~S levels and intracellular TG contents was observed ([figure 6D](#F6){ref-type="fig"}). This observation prompted us to investigate whether H~2~S is responsible for the protection from lipid deposition within hepatocytes. We found that treatment with NaHS (H~2~S donor) reduced lipid accumulation in FFA-stimulated L02 cells (online [supplementary figure 5A, B](#SP1){ref-type="supplementary-material"}) and suppressed the expression of both MPST and CSE (online [supplementary figure 5C](#SP1){ref-type="supplementary-material"}). Furthermore, exogenous H~2~S supplementation decreased intracellular TG contents in L02 cells treated with both MPST and CSE siRNAs ([figure 6E](#F6){ref-type="fig"}). Finally, the incubation of FFA-treated cells with NaHS prevented the exacerbation of fat accumulation induced by MPST overexpression ([figure 6F](#F6){ref-type="fig"}). These data suggest that MPST regulated H~2~S production through a CSE-dependent mechanism and that H~2~S mediates the potent anti-fatty liver effects in the MPST regulation of hepatocyte steatosis.

![MPST attenuates H~2~S production and subsequently promotes fat accumulation in hepatocytes through CSE dependent-mechanism. (A--C) After transfection with scrambled siRNA (negative control) and MPST siRNA for 24 hours, L02 cells were transfected with or without CSE siRNA for 24 hours. Then the cells were treated with FFAs (1 mM) for another 24 hours and subjected to western blot analyses (A). The fresh supernatants were collected to measure H~2~S levels (B). Representative Oil Red O staining images and measurements of intracellular TG content are shown in (C). Original magnification ×400. (D) The correlation between supernatant H~2~S levels and intracellular TG contents in FFA-treated L02 cells was analysed. (E) L02 cells transfected with MPST siRNA and CSE siRNA were pretreated with NaHS (1 mM) for 2 hours and then treated with FFAs (1 mM) with or without NaHS for 24 hours. Intracellular TG contents were determined. (F) L02 cells were pretreated with NaHS (1 mM) for 2 hours and then treated with FFAs (1 mM) with or without NaHS for 24 hours. Representative Oil Red O staining images and measurements of intracellular TG contents were shown. The results are expressed as the mean±SD of three independent experiments. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001. CSE, cystathionine γ-lyase; FFA, free fatty acid; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; H~2~S, hydrogen sulfide; MPST, 3-mercaptopyruvate sulfurtransferase; NaHS, sodium hydrosulfide; siRNA, small interfering RNA; TG, triglyceride.](gutjnl-2017-313778f06){#F6}

SREBP-1 pathway is involved in the MPST regulation of fat accumulation in hepatocytes {#s3g}
-------------------------------------------------------------------------------------

De novo lipogenesis (DNL) can be amplified by increases in sterol regulatory element binding protein 1c (SREBP-1), the central transcription factor that induces the expression of enzymes involved in fatty acids DNL, hepatic TG and cholesterol synthesis.[@R29] The overexpression of SREBP-1 in animal models has been identified as a contributor to lipotoxic liver injury.[@R30]

Interestingly, previous studies suggested that antisteatogenic effects of H~2~S are mediated via the modulation of SREBP-1 expression.[@R17] Here we also demonstrated that the upregulated SREBP-1 expression levels in FFA-treated L02 cells were counteracted by exogenous H~2~S supplementation, which suggests that H~2~S regulated lipid metabolism mainly by modulating SREBP-1 (online [supplementary figure 5C](#SP1){ref-type="supplementary-material"}). Therefore, we hypothesized that MPST regulates fat accumulation via regulation of H~2~S production and SREBP-1 expression. As illustrated in [figure 7A](#F7){ref-type="fig"}, inhibition of MPST markedly downregulated hepatic expression of SREBP-1 protein and its downstream proteins including fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC) in HFD-fed mice. In parallel with in vivo results, knockdown of MPST in the FFA-stimulated L02 cells markedly inhibited the protein expressions of SREBP-1 and its downstream proteins ([figure 7B](#F7){ref-type="fig"}). In contrast, the overexpression of MPST significantly upregulated SREBP-1, ACC and FAS expressions in the FFA-stimulated L02 cells ([figure 7C](#F7){ref-type="fig"}). Furthermore, MPST siRNA-mediated downregulation of SREBP-1, ACC and FAS was restored by CSE siRNA treatment in FFA-treated L02 cells ([figure 7D](#F7){ref-type="fig"}). Finally, co-IP assay results demonstrated the protein--protein interaction between MPST and SREBP-1.

![SREBP-1 pathway is involved in MPST-regulated fat accumulation in hepatocytes. (A) HFD-fed C57/BL6 mice were given 1×10^9^ plaque-forming units of AD-GFP or AD-shMPST via the tail vein every 2 weeks from the beginning of experiment and were sacrificed after 8 weeks of HFD feeding. Liver tissues were subjected to western blot analyses. (B) After transfection with scrambled siRNA (negative control) and MPST siRNA for 24 hours, L02 cells were treated with FFAs (1 mM) for 24 hours. Western blot analyses were performed to determine SREBP-1, FAS and ACC protein expressions. (C) After transfecting with plasmid containing GFP with or without full-length MPST DNA for 24 hours, L02 cells were treated with FFAs (1 mM) for 24 hours. Western blot analyses were performed. (D) After the transfection with NC and MPST siRNA for 24 hours, L02 cells were transfected with or without CSE siRNA for 24 hours. Then the cells were treated with FFAs (1 mM) for another 24 hours and subjected to western blot analyses. (E) Immunoblot analysis of the interaction between MPST and SREBP-1 by co-immunoprecipitation. FFA-treated L02 cells were transfected with Flag-MPST and subjected to immunoprecipitation with an anti-Flag monoclonal antibody. Co-immunoprecipitated SREBP-1 was detected with an anti-SREBP-1 antibody. The results are expressed as the mean±SD of five mice per group or three independent experiments. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001. ACC, acetyl-CoA carboxylase; CSE, cystathionine γ-lyase; FAS, fatty acid synthase; FFA, free fatty acid; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GFP, green fluorescent protein; HFD, high fat diet; IB, immunoblot; IP, immunoprecipitation; MPST, 3-mercaptopyruvate sulfurtransferase; siRNA, small interfering RNA; SREBP-1, sterol regulatory element-binding protein 1c.](gutjnl-2017-313778f07){#F7}

Disturbances in fatty acid oxidation also account for excess lipid storage in the liver. The key enzymes of fatty acid oxidation pathways in the liver are regulated by peroxisome proliferator-activated receptor α (PPARα), the expression of which has been found to be modulated in H~2~S-regulated hepatic steatosis.[@R17] However, in this study, we found that partial knockdown of MPST did not affect the expression of genes involved in fatty acid β-oxidation that were mainly regulated by PPARα in HFD-fed mice (online [supplementary figure 6A, B](#SP1){ref-type="supplementary-material"}). The overexpression of MPST did not affect the expression of PPARα targeted downstream genes in FFA-treated L02 cells either (online [supplementary figure 6C](#SP1){ref-type="supplementary-material"}). Moreover, neither the reduction of endogenous H~2~S nor the exogenous H~2~S supplementation affected CPT1A, FGF21, medium-chain acyl-CoA dehydrogenase or long-chain acyl-CoA dehydrogenase protein levels in FFA-treated L02 cells (online [supplementary figure 6D, E](#SP1){ref-type="supplementary-material"}). These data indicate that fat oxidation pathways may not be involved in the effect of MPST regulation on NAFLD.

Knockdown of MPST weakens JNK phosphorylation and ameliorates hepatic oxidative stress {#s3h}
--------------------------------------------------------------------------------------

H~2~S was also reported to protect against liver injury by suppressing the C-Jun N-terminal kinase (JNK) signalling pathway,[@R32] which is activated in steatotic hepatocytes and regulates oxidative stress and subsequent inflammation.[@R33] Thus, we evaluated the effect of MPST on JNK signalling, oxidative stress and inflammation. As illustrated in [figure 8A, B](#F8){ref-type="fig"}, knockdown of hepatic MPST remarkably inhibited JNK phosphorylation in the livers of HFD-fed mice ([figure 8A](#F8){ref-type="fig"}) and in the FFA-treated L02 cells ([figure 8B](#F8){ref-type="fig"}). In contrast, overexpression of MPST significantly enhanced JNK phosphorylation in the FFA-stimulated L02 cells ([figure 8C](#F8){ref-type="fig"}).

![Knockdown of MPST weakens JNK phosphorylation, ameliorates hepatic oxidative stress and suppresses the release of MCP-1. (A--C) Western blots and the quantifications of the ratio of JNK phosphorylation over total JNK, as quantified by densitometry from the immunoblots after normalisation to GAPDH expression, from HFD-fed mice with AD-shMPST or AD-GFP treatment (A), from FFA-treated L02 cells with siMPST or siNC transfection (B) or from FFA-treated L02 cells with GFP-MPST or GFP transfection (C). Transfections with short hairpin RNA or vector and treatment with FFA are the same as described in other figures. (D) Liver tissues from HFD-fed mice after adenovirus-mediated knockdown of MPST were subjected to intrahepatic MDA measurements (left panel). L02 cells were transfected with NC or MPST siRNA for 24 hours and then were treated with FFAs (1 mM) for 24 hours. Intracellular MDA contents and SOD activity were measured. (E) After transfecting with NC and MPST siRNA for 24 hours, L02 cells were transfected with or without CSE siRNA for 24 hours. Then the cells were treated with FFAs (1 mM) for another 24 hours and subjected to intracellular MDA content measurements. (F) Liver tissues from HFD-fed mice after adenovirus-mediated knockdown of MPST were subjected to real-time quantitative PCR for MCP-1 mRNA level determination (upper panel). Plasma samples were collected to measure MCP-1 levels with an ELISA kit (lower panel). The results are expressed as the mean±SD of five mice per group or three independent experiments. \*p\<0.05, \*\*p\<0.01. (G) Proposed model by which FFA promotes NAFLD via the dysregulation of the MPST/H~2~S pathway. In NAFLD, elevated FFA flux upregulates hepatic MPST expression and then downregulates CSE expression via a direct MPST--CSE interaction, which subsequently reduces H~2~S production. The decreased H~2~S levels result in increased expression of the lipogenic enzyme SREBP-1 and its downstream genes including ACC and FAS, leading to the increased de novo synthesis of fatty acids and the subsequent increase of TG as well as cholesterol contents, triggering the malignant cycle of aggravated lipid accumulation in the liver accompanied by increased secretion of VLDL. On the other hand, the reduced H~2~S levels result in the activation of JNK phosphorylation signalling and aggravate hepatic oxidative stress as well as provoke MCP-1 release, synergistically contributing to the exacerbation of NAFLD. ACC, acetyl-CoA carboxylase; CSE, cystathionine γ-lyase; FAS, fatty acid synthase; FFA, free fatty acid; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GFP, green fluorescent protein; HFD, high fat diet; JNK, C-Jun N-terminal kinase; MDA, malondialdehyde; MPST, 3-mercaptopyruvate sulfurtransferase; mRNA, messenger RNA; siRNA, small interfering RNA; SOD, superoxide dismutase; SREBP-1, sterol regulatory element-binding protein 1c; TG, triglyceride; VLDL, very-low-density lipoprotein.](gutjnl-2017-313778f08){#F8}

Increased intrahepatic levels of FFAs provide a source of oxidative stress, and consequently, lipid peroxidation promotes NAFLD progression.[@R35] We found that knockdown of hepatic MPST markedly reduced intrahepatic malondialdehyde (MDA) contents in the HFD-fed mice and in L02 cells, while superoxide dismutase activity in L02 cells was significantly enhanced by MPST inhibition ([figure 8D](#F8){ref-type="fig"}). Furthermore, the additional knockdown of CSE by siRNA restored the MDA content in siMPST-treated L02 cells ([figure 8E](#F8){ref-type="fig"}). Among the inflammatory genes, hepatic gene expression and circulating level of MCP-1 were significantly suppressed after partial knockdown of hepatic MPST in HFD-fed mice ([figure 8F](#F8){ref-type="fig"}, online [supplementary figure 7](#SP1){ref-type="supplementary-material"}), while most of the other inflammatory gene profiles and circulating inflammatory biomarkers were not altered after MPST inhibition (online [supplementary figure 7](#SP1){ref-type="supplementary-material"}).

Discussion {#s4}
==========

In this study, we provided evidence that the FFA-induced pathologic upregulation of MPST in hepatocytes is involved in the pathogenesis of NAFLD via inhibition of the CSE/H~2~S pathway and consequent upregulation of SREBP-1, JNK and oxidative stress pathways. We have integrated each of these findings in a model (summarised in [figure 8G](#F8){ref-type="fig"}) that depicts a novel important pathway by which FFAs promote NAFLD. The rational for this model is presented in the following discussion.

Impaired endogenous H~2~S synthesis was reported to be associated with hepatic fibrosis and cirrhosis[@R13] and fatty liver induced by HFD feeding[@R16] or methionine and choline-deficient (MCD) diet feeding.[@R17] In this study, we also confirmed that H~2~S levels were reduced in cellular and mouse models of NAFLD. However, the molecular explanation for why H~2~S synthesis is impaired in NAFLD remains unclear. The CBS/CSE system is considered to be responsible for the majority of endogenous H~2~S production, while MPST, the maximal activity of which is attained under non-physiologic alkaline conditions using 3-mercaptopyruvate as substrate, plays a quite different role in the generation of H~2~S.[@R38] Previous studies reported that the deficiency of CSE in mice decreased endogenous H~2~S level,[@R10] which is in agreement with an important role of CSE in promoting H~2~S production. Theoretically, MPST also stimulates H~2~S production from a persulfurated acceptor substrate.[@R21] However, surprisingly, in the current study, we found that inhibition of MPST via either administration of adenovirus-mediated shRNA or heterozygous deletion of the *Mpst* gene markedly increased H~2~S production and attenuated HFD-induced hepatic steatosis. Our mechanistic studies suggest that MPST inhibits H~2~S production via the downregulation of CSE. In addition, we provided several lines of evidence suggesting that MPST downregulates CSE via the protein--protein interaction. First, based on the prediction from the protein--protein interaction database, we uncovered a direct and functional interaction between MPST and CSE. An analysis of the STRING database revealed that the score of prediction for the MPST--CSE interaction ranks the first place among the top 10 functional MPST-centric protein-interaction networks. Second, hepatic CSE expression was significantly upregulated in response to a moderate reduction in MPST expression, while the overexpression of MPST induced significant downregulation of CSE expression. Finally, co-IP analyses showed that MPST directly interacted with CSE, establishing a molecular mechanism underlying the feedback regulations between these two H~2~S-generating enzymes. In addition, by inhibiting the upregulated CSE expression in the MPST-knockdown FFA-treated L02 cells, we found that H~2~S levels were significantly decreased compared with the siMPST alone groups, validating a CSE dependency of MPST-mediated inhibition of H~2~S production. These results imply a negative feedback between MPST and CSE, which cooperates with each other to maintain H~2~S-metabolism homeostasis. Interestingly, a similar compensatory regulation was also found between CBS and CSE in the livers of HFD-fed mice.[@R16] Analogously, another recent study reported that DL-propargylglycine, an inhibitor of CSE, increases CBS-mediated desulfhydration in hepatocytes, implying a compensatory mechanism of H~2~S production.[@R39]

Up to date, the impact of H~2~S on liver lipid metabolism remains unclear. A recent study found that H~2~S treatment reduced serum TG levels and counteracted steatosis in HFD-fed mice.[@R26] Previous studies have demonstrated the impact of altered endogenous H~2~S levels on the plasma lipid profile in CSE-deficient or CBS-deficient mice.[@R25] In this study, we found that elevated intrahepatic H~2~S levels, induced by MPST partial knockdown, were associated with attenuated hepatic steatosis in HFD-fed mice. In cultured cells, H~2~S levels also negatively correlated with the intracellular TG contents. Additionally, we provided several lines of conclusive evidence supporting H~2~S-mediated amelioration of steatosis. First, inhibition of CSE eliminated the compensatory upregulation of CSE in the MPST-knockdown cells, resulting in rebounded hepatocyte steatosis. Second, administration of NaHS improved lipid accumulation and prevented the exacerbation of fat accumulation induced by MPST overexpression in FFA-stimulated L02 cells. Finally, exogenous H~2~S supplementation reversed the augmentation of intracellular TG contents in hepatocytes that exhibited a reduced H~2~S decline after the double inhibition of MPST/CSE. Collectively, impaired H~2~S synthesis may be an important cause for NAFLD, and MPST promotes fat accumulation in hepatocytes via the inhibition of H~2~S production.

Another important finding from the current study is the identification of the mechanism by which H~2~S regulates lipid metabolism. Hepatic lipid accumulation results from an imbalance between lipid synthesis and lipid disposal. We found that elevated H~2~S levels were associated with the significant suppression of SREBP-1, FAS and ACC in cellular and mouse model of NAFLD after MPST inhibition. In contrast, MPST overexpression reduced H~2~S production and promoted SREBP-1 expression. Further study showed that exogenous H~2~S supplementation suppressed the expression of SREBP-1 activated by FFA stimulation, while the double inhibition of MPST and CSE decreased H~2~S production and enhanced the SREBP-1 pathway. These results suggest a significant role of H~2~S in the regulation of hepatic lipid metabolism via the modulation of the SREBP-1 pathway, a critical factor for lipid synthesis. β-Oxidation is another important step in the control of lipid metabolism, in which PPARα plays a central role in the regulation of the expression of genes that encode several mitochondrial fatty acid-catabolising enzymes in addition to mediating inducible mitochondrial and peroxisomal fatty acid β-oxidation. However, our results showed that the alteration of H~2~S level caused by the regulation of MPST in vivo and in vitro did not affect the expressions of PPARα-regulated genes involved in fatty acid β-oxidation. Furthermore, neither reduced H~2~S production due to double inhibition of MPST/CSE nor exogenous H~2~S supplementation altered the expression of β-oxidation pathway-associated genes. Therefore, the effect of MPST regulation on hepatic steatosis is largely dependent on SREBP-1-mediated lipid synthesis processing and independent from the fatty acid oxidation pathway.

H~2~S may also regulate the development of NAFLD by a SREBP-1-independent mechanism. A recent study reported that H~2~S protected against hepatic ischemia/reperfusion injury partly by weakening hepatocyte apoptosis through the suppression of the JNK signalling pathway.[@R32] As a major effector of lipotoxic injury in the liver, the JNK pathway is activated in steatotic hepatocytes and inhibition of JNK protects against hepatocyte injury by ameliorating oxidative stress and subsequent inflammation.[@R33] In this study, we found that elevated H~2~S levels induced by MPST silencing were associated with the significant inhibition of hepatic JNK phosphorylation in HFD-fed mice and in FFA-stimulated L02 cells, whereas reduced H~2~S levels induced by MPST overexpression caused opposite effects. In addition, hepatic lipotoxicity is known to generate oxidative stress and inflammation,[@R40] and H~2~S supplementation has been shown to prevent MCD-induced NASH in rats via the inhibition of oxidative stress and suppressing inflammation.[@R17] In the current study, we also found that elevated H~2~S levels were associated with significantly ameliorated oxidative stress and the marked suppression of MCP-1 expression, suggesting that MPST-regulated H~2~S is an important mediator in the JNK signalling pathway and oxidative stress as well as inflammation involved in the pathogenesis of NAFLD.

The findings of this study provide novel clues for developing potential therapeutic strategies for NAFLD. The increased endogenous H~2~S, derived from compensatory generation by CSE after partial knockdown of MPST, can easily diffuse across cell membranes in a receptor-independent manner and can activate various cellular targets, making it an attractive pharmacological agent.[@R17] Further studies are needed to clarify the detailed regulatory mechanism of MPST on H~2~S production and the subsequent impact on NAFLD.

In conclusion, our study provides new insights into the mechanism of hepatic lipotoxicity that FFA-induced upregulation of MPST is implicated in the pathogenesis of NAFLD via regulation of H~2~S in a CSE-dependent manner, identifying that MPST may be a potential therapeutic target for NAFLD.
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